TibaRay develops the Galactica™ linear accelerator platform that delivers ultra‑fast FLASH radiotherapy, reducing treatment time to fractions of a second while improving targeting precision and minimizing damage to healthy tissue. By enabling rapid, high‑dose treatments, the technology aims to increase cure rates, lower costs, and expand access to radiotherapy worldwide. The same accelerator core is also being adapted for applications beyond oncology.
Funding
Funding not disclosed
Founders
Product
Problem
Cancer radiotherapy often requires several minutes per treatment, during which tumors can move and normal tissue may be exposed to excess radiation, reducing precision and curative potential. Conventional linear accelerators are large, expensive, and limited in number, restricting access to life‑saving therapy for many patients worldwide.
Solution
TibaRay’s Galactica™ platform delivers ultra‑fast FLASH radiotherapy, completing dose delivery in a fraction of a second to “freeze” tumor motion and improve targeting accuracy. The system integrates the Leo Cancer Care upright patient positioning platform, allowing patients to be treated while seated upright, which further reduces motion and shortens setup time. By delivering high‑dose radiation in milliseconds, Galactica™ minimizes collateral damage to surrounding healthy organs, enabling higher curative doses without increasing side effects. The compact linear accelerator design lowers capital and operational costs, supporting broader deployment in hospitals and cancer centers. Together, these advances aim to make radiotherapy faster, more precise, and more accessible.
Target Audience
Primary customers are hospitals, cancer treatment centers, and radiotherapy clinics seeking to upgrade to faster, higher‑precision radiation therapy solutions.
Features
- FLASH therapy capability delivering therapeutic doses in sub‑second pulses to reduce intra‑fraction motion
- Upright patient positioning platform (Leo Cancer Care) that shortens setup and improves patient comfort
- Integrated motion‑tracking and rapid beam steering for sub‑millimeter targeting accuracy
- Compact linear accelerator architecture that reduces footprint and capital expense compared to traditional rooms
- Real‑time dose monitoring and adaptive control to ensure precise dose delivery while protecting healthy tissue